Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease

被引：1

作者：

Okabe, Hirohisa ^{[1
]}

Hayashi, Hiromitsu ^{[1
]}

Nakagawa, Shigeki ^{[1
]}

Imai, Katsunori ^{[1
]}

Nitta, Hidetoshi ^{[1
]}

Arima, Kota ^{[1
]}

Hashimoto, Daisuke ^{[1
]}

Chikamoto, Akira ^{[1
]}

Ishiko, Takatoshi ^{[1
]}

Beppu, Toru ^{[2
]}

Baba, Hideo ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Kumamoto 8608556, Japan

[2] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan

来源：

HISTOLOGY AND HISTOPATHOLOGY | 2016年 / 31卷 / 02期

关键词：

Cholangiocarcinoma; Hepatocellular carcinoma; Cancer-associated fibroblast; Hepatic stellate cell; Portal fibroblast; INTRAHEPATIC BILIARY EPITHELIUM; HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; TGF-BETA; BILE-DUCT; CHOLANGIOCARCINOMA; HEDGEHOG; PROGRESSION; ACTIVATION; RAT;

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The importance of cancer-associated fibroblasts (CAFs) in liver cancer, cholangiocarcinoma (CC) and hepatocellular carcinoma (HCC), has been appreciated in the past 5 years. We focused on how they get activated in the tumor microenvironment in this review. Not only hepatic stellate cells (HSCs) but also portal fibroblasts (PFs) have been appreciated to be key players in liver fibrogenesis, and their different roles have just started to be recognized. Since the role of cholangiocyte in biliary fibrogenic disease might have some similarities to that of CC, we focused on the role of cholangiocytes activating stromal fibroblasts, which would presumably be helpful for better understanding the mechanism of tumor-CAFs interaction. In addition, the activation of CAFs should be different from that of CAFs in HCC, which we consider to be potentially similar to MFs in hepatocyte injury-dependent liver fibrogesis. Herein, we describe the activation of CAFs in CC in comparison to MFs seen in other liver diseases such as 1) MFs in liver fibrosis caused by hepatocyte injury such as alcoholic hepatitis, viral hepatitis, and nonalcoholic steatosis, 2) MFs in liver fibrosis caused by cholestatic disease, and 3) CAFs in hepatocellular carcinoma (HCC). This review on the activation of fibroblasts either in liver cancer or in chronic liver disease would contribute to CAF-targeted therapy in liver cancer.

引用

页码：141 / 148

页数：8

共 75 条

[1] The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis [J].

Alvaro, D ;

Metalli, VD ;

Alpini, G ;

Onori, P ;

Franchitto, A ;

Barbaro, B ;

Glaser, SS ;

Francis, H ;

Cantafora, A ;

Blotta, I ;

Attili, AF ;

Gaudio, E .

JOURNAL OF HEPATOLOGY, 2005, 43 (05) :875-883

[2] Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors [J].

Andersen, Jesper B. ;

Spee, Bart ;

Blechacz, Boris R. ;

Avital, Itzhak ;

Komuta, Mina ;

Barbour, Andrew ;

Conner, Elizabeth A. ;

Gillen, Matthew C. ;

Roskams, Tania ;

Roberts, Lewis R. ;

Factor, Valentina M. ;

Thorgeirsson, Snorri S. .

GASTROENTEROLOGY, 2012, 142 (04) :1021-U552

[3] Stromal fibroblasts in cancer initiation and progression [J].

Bhowmick, NA ;

Neilson, EG ;

Moses, HL .

NATURE, 2004, 432 (7015) :332-337

[4] TGFβ:: the molecular Jekyll and Hyde of cancer [J].

Bierie, Brian ;

Moses, Harold L. .

NATURE REVIEWS CANCER, 2006, 6 (07) :506-520

[5] Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping [J].

Borger, Darrell R. ;

Tanabe, Kenneth K. ;

Fan, Kenneth C. ;

Lopez, Hector U. ;

Fantin, Valeria R. ;

Straley, Kimberly S. ;

Schenkein, David P. ;

Hezel, Aram F. ;

Ancukiewicz, Marek ;

Liebman, Hannah M. ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Ryan, David P. ;

Deshpande, Vikram ;

Dias-Santagata, Dora ;

Ellisen, Leif W. ;

Zhu, Andrew X. ;

Iafrate, A. John .

ONCOLOGIST, 2012, 17 (01) :72-79

[6] Pro-fibrogenic potential of PDGF-D in liver fibrosis [J].

Borkham-Kamphorst, Erawan ;

van Roeyen, Claudia R. C. ;

Ostendorf, Tammo ;

Floege, Juergen ;

Gressner, Axel M. ;

Weiskirchen, Ralf .

JOURNAL OF HEPATOLOGY, 2007, 46 (06) :1064-1074

[7] Distinct proteomic features of two fibrogenic liver cell populations: Hepatic stellate cells and portal myofibroblasts [J].

Bosselut, Nelly ;

Housset, Chantal ;

Marcelo, Paulo ;

Rey, Colette ;

Burmester, Thorsten ;

Vinh, Joeelle ;

Vaubourdolle, Michel ;

Cadoret, Axelle ;

Baudin, Bruno .

PROTEOMICS, 2010, 10 (05) :1017-1028

[8] Platelet-Derived Growth Factor-D and Rho GTPases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma [J].

Cadamuro, Massimiliano ;

Nardo, Giorgia ;

Indraccolo, Stefano ;

Dall'Olmo, Luigi ;

Sambado, Luisa ;

Moserle, Lidia ;

Franceschet, Irene ;

Colledan, Michele ;

Massani, Marco ;

Stecca, Tommaso ;

Bassi, Nicolo ;

Morton, Stuart ;

Spirli, Carlo ;

Fiorotto, Romina ;

Fabris, Luca ;

Strazzabosco, Mario .

HEPATOLOGY, 2013, 58 (03) :1042-1053

[9] Apoptosis: The nexus of liver injury and fibrosis [J].

Canbay, A ;

Friedman, S ;

Gores, GJ .

HEPATOLOGY, 2004, 39 (02) :273-278

[10]

Chen TC, 2012, ANN SURG ONCOL, V19, pS675, DOI [10.1245/s10434-012-2224-7, 10.1245/s10434-012-2451-y]

← 1 2 3 4 5 6 7 8 →